Literature DB >> 8094611

Virological investigations of specimens from buffaloes affected by buffalopox in Maharashtra State, India between 1985 and 1987.

K Dumbell1, M Richardson.   

Abstract

Isolates of poxviruses were made from thirteen of eighteen specimens of scabs taken from pox lesions on buffaloes in five different districts of Maharashtra State, India, between December, 1985 and February, 1987. The biological characters of twelve of the isolates resembled those of the Hissar strain of buffalopox virus; the thirteenth isolate appeared to be vaccinia. The Hin dIII restriction profiles of DNA from all 13 isolates and from the Hissar strain were typical of those given by vaccinia strains. DNA from all twelve Maharashtra buffalopox (BPV) isolates gave identical profiles with each of three additional endonucleases; these viruses appear to be repeated isolations of a single strain of BPV. The DNA profile of this strain was not the same as that of the Hissar strain of BPV and both could readily be distinguished from each of the three strains of vaccinia virus which had been used in India. The thirteenth Maharashtra isolate was indistinguishable from vaccinia in its biological properties, but the restriction profile of its DNA differed from those of three vaccinia strains and the BPV isolates. These observations, made 6-8 years after cessation of smallpox vaccination indicate that BPV is an emerging enzootic virus and is a subspecies of vaccinia virus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094611     DOI: 10.1007/bf01309438

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  12 in total

1.  The titration of vaccinial neutralizing antibody on chorio-allantoic membranes.

Authors:  E A BOULTER
Journal:  J Hyg (Lond)       Date:  1957-12

2.  The biological characters of several strains of vaccinia, cowpox and rabbitpox viruses.

Authors:  F FENNER
Journal:  Virology       Date:  1958-06       Impact factor: 3.616

3.  Orthopoxvirus DNA: strain differentiation by electrophoresis of restriction endonuclease fragmented virion DNA.

Authors:  J J Esposito; J F Obijeski; J H Nakano
Journal:  Virology       Date:  1978-08       Impact factor: 3.616

Review 4.  Buffalopox-a review.

Authors:  S M Lal; I P Singh
Journal:  Trop Anim Health Prod       Date:  1977-05       Impact factor: 1.559

5.  Conservation and variation in Orthopoxvirus genome structure.

Authors:  M Mackett; L C Archard
Journal:  J Gen Virol       Date:  1979-12       Impact factor: 3.891

6.  Comparison of five poxvirus genomes by analysis with restriction endonucleases HindIII, BamI and EcoRI.

Authors:  H K Müller; R Wittek; W Schaffner; D Schümperli; A Menna; R Wyler
Journal:  J Gen Virol       Date:  1978-01       Impact factor: 3.891

7.  Serological relationship of buffalopox virus to vaccinia and cowpox viruses.

Authors:  R S Kataria; I P Singh
Journal:  Acta Virol       Date:  1970-07       Impact factor: 1.162

8.  Comparative studies on buffalo pox, vaccinia and cow pox viruses in hamster kidney cell cultures.

Authors:  T Mathew
Journal:  Acta Virol       Date:  1970-11       Impact factor: 1.162

9.  Buffalopox virus.

Authors:  D Baxby; B J Hill
Journal:  Vet Rec       Date:  1969-09-13       Impact factor: 2.695

10.  Virus study of pock disease among buffaloes.

Authors:  T Mathew
Journal:  Indian J Pathol Bacteriol       Date:  1967-01
View more
  14 in total

1.  Detection and differentiation of old world orthopoxviruses: restriction fragment length polymorphism of the crmB gene region.

Authors:  V N Loparev; R F Massung; J J Esposito; H Meyer
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

Review 2.  Smallpox vaccines: targets of protective immunity.

Authors:  Bernard Moss
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

3.  Partial antigenic characterization of buffalopox virus.

Authors:  P Anand Kumar; G Butchaiah
Journal:  Vet Res Commun       Date:  2004-08       Impact factor: 2.459

4.  Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.

Authors:  Jitendra Kumar; Viveka Nand Yadav; Swastik Phulera; Ashish Kamble; Avneesh Kumar Gautam; Hemendra Singh Panwar; Arvind Sahu
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

5.  Araçatuba virus: a vaccinialike virus associated with infection in humans and cattle.

Authors:  Giliane de Souza Trindade; Flávio Guimarães da Fonseca; João Trindade Marques; Maurício Lacerda Nogueira; Luiz Claudio Nogueira Mendes; Alexandre Secorun Borges; Juliana Regina Peiró; Edviges Maristela Pituco; Cláudio Antônio Bonjardim; Paulo César Peregrino Ferreira; Erna Geessien Kroon
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

6.  PCR strategy for identification and differentiation of small pox and other orthopoxviruses.

Authors:  S L Ropp; Q Jin; J C Knight; R F Massung; J J Esposito
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

7.  Emergence and reemergence of vaccinia-like viruses: global scenario and perspectives.

Authors:  R K Singh; V Balamurugan; V Bhanuprakash; G Venkatesan; M Hosamani
Journal:  Indian J Virol       Date:  2012-04-04

8.  Raccoon poxvirus rabies virus glycoprotein recombinant vaccine in sheep.

Authors:  J C DeMartini; H M Bickle; S J Brodie; B X He; J J Esposito
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  Nosocomial buffalopoxvirus infection, Karachi, Pakistan.

Authors:  Afia Zafar; Robert Swanepoel; Roger Hewson; Mazhar Nizam; Altaf Ahmed; Akhtar Husain; Antoinette Grobbelaar; Kevin Bewley; Valerie Mioulet; Barry Dowsett; Linda Easterbrook; Rumina Hasan
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

10.  Brazilian vaccinia viruses and their origins.

Authors:  Giliane S Trindade; Ginny L Emerson; Darin S Carroll; Erna G Kroon; Inger K Damon
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.